526445 — Indrayani Biotech Balance Sheet
0.000.00%
- IN₹619.29m
- IN₹2.26bn
- IN₹1.30bn
- 25
- 63
- 19
- 24
Annual balance sheet for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6.79 | 15 | 127 | 5.82 | 2.88 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 78.5 | 154 | 323 | 724 | 1,101 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 96.2 | 189 | 775 | 1,450 | 1,779 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 253 | 259 | 479 | 594 | 600 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 401 | 514 | 1,560 | 2,340 | 2,679 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 118 | 195 | 719 | 871 | 1,025 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 203 | 272 | 1,009 | 1,668 | 1,954 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 197 | 242 | 551 | 672 | 725 |
| Total Liabilities & Shareholders' Equity | 401 | 514 | 1,560 | 2,340 | 2,679 |
| Total Common Shares Outstanding |